Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cholesterol in myelin biogenesis and hypomyelinating disorders.
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal.
(1)H magnetic resonance spectroscopy in multiple sclerosis and related disorders.
Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
The Epidemiologic Evidence Linking Autoimmune Diseases and Psychosis.
MHC and non-MHC gene regulation of disease susceptibility and disease course in experimental inflammatory peripheral neuropathy.
Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes.
Aquaporin-4 antibody negative recurrent isolated optic neuritis: Clinical evidence for disease heterogeneity.
Developmental cuprizone exposure impairs oligodendrocyte lineages differentially in cortical and white matter tissues and suppresses glutamatergic neurogenesis signals and synaptic plasticity in the hippocampal dentate gyrus of rats.
Options in improving respiratory function in multiple sclerosis.
Helicobacter pylori and autoimmune disease: Cause or bystander.
Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report.
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Multiple sclerosis: Reactivation of Epstein-Barr or herpes viruses not associated with MS relapse.
Association of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism With Multiple Sclerosis in Turkish Patients.
Disease-modifying agents in multiple sclerosis.
SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.
Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait.
Does fatigue complaint reflect memory impairment in multiple sclerosis?
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).
Metabotropic glutamate receptor 5 modulates calcium oscillation and innate immune response induced by lipopolysaccharide in microglial cell.
Plant sterols: Friend or foe in CNS disorders?
Oncostatin M protects against demyelination by inducing a protective microglial phenotype.
Propentofylline reverses delayed remyelination in streptozotocin-induced diabetic rats.
The correlation of HLA-G with multiple sclerosis.
Pages
« first
‹ previous
…
508
509
510
511
512
513
514
515
516
…
next ›
last »